Vor Biopharma Inc. · NASDAQ:VOR
Shah Rajeev M. sold 620,133 Vor Biopharma Inc. shares (Form 4)
Traded Apr 8 to Apr 10, 2026 · Filed Apr 10, 2026
From Apr 8 to Apr 10, 2026, Shah Rajeev M. (Director, 10% owner) sold 620,133 Vor Biopharma Inc. shares at an average US$16.50 for US$10.2M, leaving 3,935,608 shares. Filed Apr 10, 2026 (Form 4).
- Sold
- 620,133 shares
- Price
- US$16.50 average (US$15.75 to US$16.91)
- Value
- US$10.2M
- Holding after
- 3,935,608 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 8, 2026 | Common Stock | Sale | 353,242 | US$16.32 | 4,202,499 | Indirect |
| Apr 8, 2026 | Common Stock | Sale | 130,862 | US$16.91 | 4,071,637 | Indirect |
| Apr 9, 2026 | Common Stock | Sale | 135,201 | US$16.59 | 3,936,436 | Indirect |
| Apr 10, 2026 | Common Stock | Sale | 828 | US$15.75 | 3,935,608 | Indirect |
Source
Related
- Vor Biopharma Inc.
- Shah Rajeev M.
- Vor Biopharma Inc. shareholders
- Form 4 · Shah Rajeev M. · Jul 21, 2026
- Form 4 · Shah Rajeev M. · Apr 24, 2026
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026